Published in Genet Test on March 01, 2008
Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol (2014) 1.91
Physicians' experiences with BRCA1/2 testing in community settings. J Clin Oncol (2008) 1.29
Returning individual research results: development of a cancer genetics education and risk communication protocol. J Empir Res Hum Res Ethics (2010) 1.22
Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.19
A study of the practice of individual genetic counsellors and genetic nurses in Europe. J Community Genet (2012) 1.01
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease. Genet Med (2012) 0.95
The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees' outcome. Fam Cancer (2012) 0.93
Real world experience with cancer genetic counseling via telephone. Fam Cancer (2010) 0.93
Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst (2014) 0.93
Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition. JMIR Res Protoc (2014) 0.83
Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med (2014) 0.82
Communication of genetic test results to family and health-care providers following disclosure of research results. Genet Med (2013) 0.81
Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. Patient Educ Couns (2013) 0.79
The evolution of personalized cancer genetic counseling in the era of personalized medicine. Fam Cancer (2012) 0.79
Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling. J Genet Couns (2015) 0.78
Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology (2014) 0.77
Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. J Clin Oncol (2016) 0.75
Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Fam Cancer (2016) 0.75
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax (2007) 2.86
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet (2003) 2.81
Reversible coma in children after improper baclofen pump insertion. Paediatr Anaesth (2002) 2.02
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res (2010) 1.89
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest (2011) 1.89
Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol (2002) 1.86
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res (2010) 1.82
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol (2009) 1.81
Resveratrol in human cancer chemoprevention--choosing the 'right' dose. Mol Nutr Food Res (2011) 1.77
What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One (2011) 1.74
Take note(s): differential EHR satisfaction with two implementations under one roof. J Am Med Inform Assoc (2003) 1.73
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol (2002) 1.69
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev (2002) 1.68
Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol (2004) 1.66
Clinical trials of resveratrol. Ann N Y Acad Sci (2011) 1.66
Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med (2014) 1.57
Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2009) 1.50
Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model. Ann Behav Med (2014) 1.49
Educating African American men about the prostate cancer screening dilemma: a randomized intervention. Cancer Epidemiol Biomarkers Prev (2006) 1.48
Correspondence regarding M. Sharma et al., "Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture". Biochem Biophys Res Commun (2003) 1.41
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer (2011) 1.41
Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Support Care Cancer (2007) 1.40
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver. Hum Gene Ther (2006) 1.39
Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev Res (Phila) (2009) 1.31
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol (2009) 1.30
Barriers to colorectal cancer screening: inadequate knowledge by physicians. Mt Sinai J Med (2005) 1.30
Development and evaluation of a culturally tailored educational video: changing breast cancer-related behaviors in Chinese women. Health Educ Behav (2007) 1.28
Implementing an expressive writing study in a cancer clinic. Oncologist (2008) 1.25
The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis (2006) 1.25
Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol (2006) 1.22
The development of a web- and a print-based decision aid for prostate cancer screening. BMC Med Inform Decis Mak (2010) 1.21
Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet C Semin Med Genet (2006) 1.21
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat (2006) 1.20
An audit of results of a no-drainage practice policy after hepatectomy. Am J Surg (2002) 1.20
Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.19
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology (2009) 1.17
Quality of life among immigrant Latina breast cancer survivors: realities of culture and enhancing cancer care. J Cancer Educ (2011) 1.17
Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test (2007) 1.16
Disparities in cervical cancer screening between Asian American and Non-Hispanic white women. Cancer Epidemiol Biomarkers Prev (2008) 1.16
DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell (2013) 1.14
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. Clin Cancer Res (2008) 1.12
Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). J Pediatr Psychol (2008) 1.12
A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer. Mol Ther (2008) 1.09
Risk of Buruli ulcer and detection of Mycobacterium ulcerans in mosquitoes in southeastern Australia. PLoS Negl Trop Dis (2011) 1.09
Knowledge, cultural, and attitudinal barriers to mammography screening among nonadherent immigrant Chinese women: ever versus never screened status. Cancer (2009) 1.08
Developing and validating a measure of Chinese cultural views of health and cancer. Health Educ Behav (2007) 1.08
Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomarkers Prev (2012) 1.08
High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease. Med Oncol (2010) 1.06
Social correlates of distress following hematopoietic stem cell transplantation: exploring the role of loneliness and cognitive processing. J Health Psychol (2012) 1.05
Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychol (2005) 1.05
Can assessment for obstructive sleep apnea help predict postadenotonsillectomy respiratory complications? Anesthesiology (2002) 1.05
Implementation of culturally targeted patient navigation system for screening colonoscopy in a direct referral system. Health Educ Res (2013) 1.05
Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat (2002) 1.04
Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Med Decis Making (2010) 1.03
Childhood sleep apnea and neighborhood disadvantage. J Pediatr (2010) 1.02
The role of social cognitive processing theory and optimism in positive psychosocial and physical behavior change after cancer diagnosis and treatment. Psychooncology (2007) 1.01
Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med (2013) 1.00
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC Cardiovasc Imaging (2012) 1.00
Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence. Cancer Causes Control (2008) 0.99
Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. J Clin Oncol (2003) 0.99
Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev (2002) 0.99
Enhancing informed choice to undergo health screening: a systematic review. Am J Health Behav (2013) 0.98
Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila) (2012) 0.96
Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med (2004) 0.96
Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire. Patient Educ Couns (2005) 0.96
Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers. J Genet Couns (2003) 0.96
Results of a randomized controlled trial testing the efficacy of a culturally targeted and a generic video on mammography screening among chinese-american immigrants. Cancer Epidemiol Biomarkers Prev (2012) 0.95
Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results. Health Psychol (2009) 0.95
On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children. Fam Cancer (2009) 0.95
Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA. Carcinogenesis (2002) 0.94
Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. J Health Psychol (2011) 0.94
Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry. Cancer Res (2003) 0.94
Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology (2012) 0.94
A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Ann Surg Oncol (2006) 0.94
Randomized comparison of vaginal and rectal measurement of intra-abdominal pressure during subtracted dual-channel cystometry. Urology (2005) 0.93
Association between temporal orientation and attitudes about BRCA1/2 testing among women of African descent with family histories of breast cancer. Patient Educ Couns (2008) 0.92
Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives. Psychooncology (2013) 0.92
BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Res Treat (2010) 0.92
Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol (2014) 0.92
Prostate cancer screening and shared decision-making preferences among African-American members of the Prince Hall Masons. Psychooncology (2008) 0.91
Validation of the group-based medical mistrust scale among urban black men. J Gen Intern Med (2010) 0.91
BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Fam Cancer (2011) 0.91
Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer. Patient Educ Couns (2013) 0.90